Skip to main content
. 2022 Nov 25;14(2):135–147. doi: 10.1007/s12687-022-00619-7

Table 2.

Deterministic results for ONDRISeq versus out-of-country genetic testing

Total cost (CAD) per patient Total QALYs per patient Incremental cost (ONDRISeq—OOC) per patient Incremental QALYs (ONDRISeq—OOC) per patient Incremental cost- effectiveness ratio per patient Incremental net monetary benefit (at $50,000 per QALY; CAD) per patient
OOC $324,058 10.801
ONDRISeq $324,005 10.802  − $53.56 0.0014 Dominates OOC $127.49